APA Alıntı

Zhou, X., Steinhardt, M. J., Grathwohl, D., Meckel, K., Nickel, K., Leicht, H., . . . Kortüm, K. M. (2020). Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab (“Pom‐PAD‐Dara”) in relapsed/refractory multiple myeloma. Cancer Med.

Chicago Stili Alıntı

Zhou, Xiang, et al. "Multiagent Therapy With Pomalidomide, Bortezomib, Doxorubicin, Dexamethasone, and Daratumumab (“Pom‐PAD‐Dara”) in Relapsed/refractory Multiple Myeloma." Cancer Med 2020.

MLA Alıntı

Zhou, Xiang, et al. "Multiagent Therapy With Pomalidomide, Bortezomib, Doxorubicin, Dexamethasone, and Daratumumab (“Pom‐PAD‐Dara”) in Relapsed/refractory Multiple Myeloma." Cancer Med 2020.